Hairy Cell Leukemia
Showing NaN - NaN of 8
Hairy Cell Leukemia Trial run by the NCI (Moxetumomab Pasudotox-tdfk, Rituximab, Ruxience)
Active, not recruiting
- Hairy Cell Leukemia
- Moxetumomab Pasudotox-tdfk
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 26, 2023
Hairy Cell Leukemia, Hairy Cell Leukemia Variant Trial run by the NCI (CD22CART cell infusion)
Recruiting
- Hairy Cell Leukemia
- Hairy Cell Leukemia Variant
- CD22CART cell infusion
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 25, 2023
Hairy Cell Leukemia Trial run by the NCI (Anti-Tac(Fv)-PE38 (LMB-2) Immunotoxin)
Active, not recruiting
- Hairy Cell Leukemia
- Anti-Tac(Fv)-PE38 (LMB-2) Immunotoxin
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Apr 13, 2022
Hairy Cell Leukemia Trial in Poland, United States (Moxetumomab Pasudotox (CAT 8015), CAT 8015 (Moxetumomab Pasudotox))
Completed
- Hairy Cell Leukemia
- Moxetumomab Pasudotox (CAT 8015)
- CAT 8015 (Moxetumomab Pasudotox)
-
Stanford, California
- +3 more
Jan 2, 2019
Collecting and Storing Malignant, Borderline Malignant
Completed
- Acute Undifferentiated Leukemia
- +13 more
- Cytology Specimen Collection Procedure
-
Birmingham, Alabama
- +191 more
Jul 17, 2018
Hairy Cell Leukemia Trial run by the NCI (BL22 (CAT-3888))
Terminated
- Hairy Cell Leukemia
- BL22 (CAT-3888)
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Oct 7, 2015
Hairy Cell Leukemia Trial run by the NCI (Roferon-A)
Completed
- Hairy Cell Leukemia
-
Bethesda, MarylandNational Cancer Institute (NCI)
Mar 3, 2008
Leukemia, Hairy Cell Leukemia, HCL Trial in Poland, United Kingdom, United States (Immunotoxin therapy, CAT-8015 Immunotoxin,
Unknown status
- Leukemia
- +2 more
- Immunotoxin therapy
- +2 more
-
Stanford, California
- +4 more
Apr 16, 2007